Last reviewed · How we verify

Triethanolamine Salicylate (trolamine salicylate)

FDA-approved active ✓ Verified May 2026 Quality 6/100

Triethanolamine Salicylate (generic name: trolamine salicylate) is a drug. It is currently FDA-approved.

Triethanolamine Salicylate is a salt composed of protonated triethanolamine and the conjugate base of salicylic acid, salicate. It has been studied in various clinical trials for conditions such as Oral Lichen Planus, Nasopharyngeal Neoplasms, Radiodermatitis, and Wound Healing.

At a glance

Generic nametrolamine salicylate
Therapeutic areaPain
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Triethanolamine Salicylate

What is Triethanolamine Salicylate?

Triethanolamine Salicylate (trolamine salicylate) is a pharmaceutical drug.

What is the generic name of Triethanolamine Salicylate?

trolamine salicylate is the generic (nonproprietary) name of Triethanolamine Salicylate.

What development phase is Triethanolamine Salicylate in?

Triethanolamine Salicylate is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing